Vaxine Pty Ltd is a rapidly growing Australian biotechnology company based in Adelaide that has developed an impressive pipeline of vaccines against infectious disease, allergy, and cancer . Vaxine has developed the Advax range of proprietary polysaccharide adjuvants and is currently applying this state of the art adjuvant technology to development of vaccines against hepatitis B, pandemic influenza, Japanese encephalitis, West Nile virus, malaria, HIV and rabies, amongst others.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Adelaide, South Australia
- Phone
- +61 (0) 8 82044572
- sh****@****.edu.au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vaxine.net
- Keywords
- Vaccine development, Vaccine adjuvants, Vaccine clinical trials, Immunology, Artificial intelligence, Drug design, Allergy, Influenza, Cancer immunotherapy.
- HQ
- Adelaide, South Australia
Vaxine Pty Ltd Questions
Vaxine Pty Ltd's helpline number is +61 (0) 8 82044572
Vaxine Pty Ltd's website is vaxine.net
Vaxine Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/vaxine-pty-ltd
Vaxine Pty Ltd has
14 employees.
View email and phone details for 14
employees at Vaxine Pty Ltd.
Vaxine Pty Ltd's industry is
Biotechnology Research
Vaxine Pty Ltd's top competitors are
Gropep® Bioreagents Pty Ltd,
Baiyaphytopharm,
Sementis Ltd,
Kiverdi, Inc.,
Ausbiotech,
Australian Respiratory And Sleep Medicine Institute,
Biosensis Pty Ltd,
Exosome Sciences Inc,
Vaxine Care,
Vaxxas.
Vaxine Pty Ltd's support email address is sharen.pringle@flinders.edu.au
Vaxine Pty Ltd's categories are Biotechnology Research
Vaxine Pty Ltd's founding year is 2002
